Regulatory News

Filters

Date / Time Source Ticker Company Sector Market Cap Announcement
09May24 07:00 RNS AIM - Cancellation - Advanced Oncotherapy Plc
03May24 08:54 RNS Advanced Oncotherapy - Further update on financing discussions
02Apr24 15:50 RNS Advanced Oncotherapy - Further update on financing discussions
29Feb24 17:19 RNS Advanced Oncotherapy - Further update on financing discussions
01Feb24 07:00 RNS Advanced Oncotherapy - Further update on financing discussions
09Jan24 09:00 RNS Advanced Oncotherapy - Update on Financing Discussions
23Oct23 07:00 RNS Advanced Oncotherapy - Update on Financing and Current Financial Position
29Sep23 16:04 RNS Advanced Oncotherapy - Update on Financial Results
17Jul23 07:00 RNS Advanced Oncotherapy - Recapitalisation and funding plan, update on FSP
30Jun23 17:00 RNS Advanced Oncotherapy - Total Voting Rights
30Jun23 07:30 RNS AIM - Suspension - Advanced Oncotherapy PLC
30Jun23 07:15 RNS Advanced Oncotherapy - Update on financing, suspension of trading on AIM
26Jun23 10:57 RNS Advanced Oncotherapy - Partial conversion of Convertible Notes
19Jun23 17:56 RNS Advanced Oncotherapy - Partial conversion of Convertible Notes
16Jun23 18:23 RNS Advanced Oncotherapy - Issue of warrants
31May23 17:57 RNS Advanced Oncotherapy - Update on financing and convertible notes
15May23 11:36 RNS Advanced Oncotherapy - Update on Convertible Note & Loan Extension
05May23 07:00 RNS Advanced Oncotherapy - Additional funding from Secured Convertible Note
03May23 18:19 RNS Advanced Oncotherapy - Rule 2.9 Announcement
18Apr23 07:00 RNS Advanced Oncotherapy - Strategic review and formal sale process
20Mar23 12:36 RNS Advanced Oncotherapy - Update on Secured Convertible Note Facility
01Mar23 14:54 RNS Advanced Oncotherapy - Secured Convertible Note Facility & other matters
27Jan23 16:53 DGAP-News Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date
18Jan23 14:00 RNS Advanced Oncotherapy - Operational update
17Jan23 15:10 DGAP-News Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV
30Dec22 13:00 RNS Advanced Oncotherapy - Total Voting Rights
30Dec22 09:24 RNS Advanced Oncotherapy - Director/PDMR Shareholding
29Dec22 15:12 RNS Advanced Oncotherapy - Director/PDMR Shareholding
28Dec22 07:00 RNS Advanced Oncotherapy - Director/PDMR Shareholding
12Dec22 07:00 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
01Dec22 07:00 RNS Advanced Oncotherapy - Issue of Equity
28Nov22 07:00 RNS Advanced Oncotherapy - Study showcases the potential superiority of LIGHT
03Nov22 15:20 RNS Advanced Oncotherapy - Investor / Analyst Event Update
31Oct22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
27Oct22 07:31 RNS Advanced Oncotherapy - Presentation highlights superiority of LIGHT
21Oct22 07:00 RNS Advanced Oncotherapy - Notice of Investor / Analyst Event
18Oct22 07:00 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
30Sep22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
30Sep22 07:00 RNS Advanced Oncotherapy - Interim Results
29Sep22 07:15 DGAP-News Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
27Sep22 10:30 RNS Advanced Oncotherapy - LIGHT accelerator fully operational
31Aug22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
23Aug22 15:09 RNS Advanced Oncotherapy - Update re admission of Subscription Shares
19Aug22 07:00 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
03Aug22 07:00 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
29Jul22 16:30 RNS Advanced Oncotherapy - Result of AGM
30Jun22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
30Jun22 09:00 RNS Advanced Oncotherapy - Final results for the year ended 31 December 2021
28Jun22 07:00 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
13Jun22 07:00 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
31May22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
11May22 07:00 RNS Advanced Oncotherapy - LIGHT system potential in delivering FLASH
29Apr22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
27Apr22 07:00 RNS Advanced Oncotherapy - Video showcases progress on LIGHT system process
26Apr22 07:00 RNS Advanced Oncotherapy - Operational update
22Apr22 07:00 RNS Advanced Oncotherapy - Update re admission of Subscription Shares
19Apr22 16:05 RNS Advanced Oncotherapy - Update re admission of Subscription Shares
12Apr22 07:13 RNS Advanced Oncotherapy - Equity Subscription and Issue of Warrants
31Mar22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
25Mar22 09:30 RNS Advanced Oncotherapy - £2m Subscription, Add'l Loan and Issue of Warrants
14Mar22 07:15 DGAP-News Hardman & Co Research: Advanced Oncotherapy (AVO) - LIGHT: regulatory update
04Mar22 09:00 RNS Advanced Oncotherapy - Director/PDMR Notification
03Mar22 17:05 RNS Advanced Oncotherapy - Director/PDMR Notification
02Mar22 16:10 RNS Advanced Oncotherapy - Director/PDMR Notification
01Mar22 07:00 RNS Advanced Oncotherapy - Operational update
28Feb22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
17Feb22 16:25 RNS Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
31Jan22 17:00 RNS Advanced Oncotherapy - Total Voting Rights
13Jan22 15:17 RNS Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
31Dec21 13:00 RNS Advanced Oncotherapy - Total Voting Rights
13Dec21 07:00 RNS Advanced Oncotherapy - Technical update on delivery of first LIGHT system
02Dec21 13:29 RNS Advanced Oncotherapy - Issue of warrants and equity and Loan Extension
30Nov21 17:00 RNS Advanced Oncotherapy - Total Voting Rights
15Nov21 08:30 DGAP-News Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
08Nov21 14:28 RNS Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
27Oct21 07:00 RNS Advanced Oncotherapy - Presentation highlights LIGHT system superiority
30Sep21 17:00 RNS Advanced Oncotherapy - Total Voting Rights
30Sep21 07:00 RNS Advanced Oncotherapy - Interim Results
23Sep21 11:27 RNS Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
20Sep21 07:00 RNS Advanced Oncotherapy - Update re admission of Subscription Shares
03Sep21 07:00 RNS Advanced Oncotherapy - Update on admission of Subscription Shares
31Aug21 18:14 RNS Advanced Oncotherapy - Result of GM, TVR and clarification re warrants
16Aug21 16:48 RNS Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
12Aug21 13:50 DGAP-News Hardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion
11Aug21 07:00 RNS Advanced Oncotherapy - Proposed subscription and issuance of shares
02Aug21 15:37 RNS Advanced Oncotherapy - Result of AGM
30Jul21 16:58 RNS Advanced Oncotherapy - Result of AGM
13Jul21 14:19 RNS Advanced Oncotherapy - Holdings in company
30Jun21 07:00 RNS Advanced Oncotherapy - Final Results for the year ended 31 December 2020
03Jun21 07:00 RNS Advanced Oncotherapy - Saba Partners sign LOI for LIGHT system
28May21 17:00 RNS Advanced Oncotherapy - Total Voting Rights
26May21 10:37 RNS Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
28Apr21 17:38 RNS Exercise of Warrants and Issue of Equity
31Mar21 17:00 RNS Total Voting Rights
12Mar21 07:00 RNS Study shows the potential superiority of LIGHT
11Mar21 07:00 RNS Exercise of Warrants and Issue of Equity
26Feb21 17:00 RNS Total Voting Rights
17Feb21 10:39 RNS Exercise of Warrants and Issue of Equity
22Jan21 07:00 RNS Equity fundraise of c.£5.9m
13Jan21 07:00 RNS Exercise of Warrants and Issue of Equity
Date / Time Source Company % Chg
09May24 07:00 RNS
AIM - Cancellation - Advanced Oncotherapy Plc
03May24 08:54 RNS
Advanced Oncotherapy - Further update on financing discussions
02Apr24 15:50 RNS
Advanced Oncotherapy - Further update on financing discussions
29Feb24 17:19 RNS
Advanced Oncotherapy - Further update on financing discussions
01Feb24 07:00 RNS
Advanced Oncotherapy - Further update on financing discussions
09Jan24 09:00 RNS
Advanced Oncotherapy - Update on Financing Discussions
23Oct23 07:00 RNS
Advanced Oncotherapy - Update on Financing and Current Financial Position
29Sep23 16:04 RNS
Advanced Oncotherapy - Update on Financial Results
17Jul23 07:00 RNS
Advanced Oncotherapy - Recapitalisation and funding plan, update on FSP
30Jun23 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
30Jun23 07:30 RNS
AIM - Suspension - Advanced Oncotherapy PLC
30Jun23 07:15 RNS
Advanced Oncotherapy - Update on financing, suspension of trading on AIM
26Jun23 10:57 RNS
Advanced Oncotherapy - Partial conversion of Convertible Notes
19Jun23 17:56 RNS
Advanced Oncotherapy - Partial conversion of Convertible Notes
16Jun23 18:23 RNS
Advanced Oncotherapy - Issue of warrants
31May23 17:57 RNS
Advanced Oncotherapy - Update on financing and convertible notes
15May23 11:36 RNS
Advanced Oncotherapy - Update on Convertible Note & Loan Extension
05May23 07:00 RNS
Advanced Oncotherapy - Additional funding from Secured Convertible Note
03May23 18:19 RNS
Advanced Oncotherapy - Rule 2.9 Announcement
18Apr23 07:00 RNS
Advanced Oncotherapy - Strategic review and formal sale process
20Mar23 12:36 RNS
Advanced Oncotherapy - Update on Secured Convertible Note Facility
01Mar23 14:54 RNS
Advanced Oncotherapy - Secured Convertible Note Facility & other matters
27Jan23 16:53 DGAP-News
Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date
18Jan23 14:00 RNS
Advanced Oncotherapy - Operational update
17Jan23 15:10 DGAP-News
Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV
30Dec22 13:00 RNS
Advanced Oncotherapy - Total Voting Rights
30Dec22 09:24 RNS
Advanced Oncotherapy - Director/PDMR Shareholding
29Dec22 15:12 RNS
Advanced Oncotherapy - Director/PDMR Shareholding
28Dec22 07:00 RNS
Advanced Oncotherapy - Director/PDMR Shareholding
12Dec22 07:00 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
01Dec22 07:00 RNS
Advanced Oncotherapy - Issue of Equity
28Nov22 07:00 RNS
Advanced Oncotherapy - Study showcases the potential superiority of LIGHT
03Nov22 15:20 RNS
Advanced Oncotherapy - Investor / Analyst Event Update
31Oct22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
27Oct22 07:31 RNS
Advanced Oncotherapy - Presentation highlights superiority of LIGHT
21Oct22 07:00 RNS
Advanced Oncotherapy - Notice of Investor / Analyst Event
18Oct22 07:00 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
30Sep22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
30Sep22 07:00 RNS
Advanced Oncotherapy - Interim Results
29Sep22 07:15 DGAP-News
Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
27Sep22 10:30 RNS
Advanced Oncotherapy - LIGHT accelerator fully operational
31Aug22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
23Aug22 15:09 RNS
Advanced Oncotherapy - Update re admission of Subscription Shares
19Aug22 07:00 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
03Aug22 07:00 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
29Jul22 16:30 RNS
Advanced Oncotherapy - Result of AGM
30Jun22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
30Jun22 09:00 RNS
Advanced Oncotherapy - Final results for the year ended 31 December 2021
28Jun22 07:00 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
13Jun22 07:00 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
31May22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
11May22 07:00 RNS
Advanced Oncotherapy - LIGHT system potential in delivering FLASH
29Apr22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
27Apr22 07:00 RNS
Advanced Oncotherapy - Video showcases progress on LIGHT system process
26Apr22 07:00 RNS
Advanced Oncotherapy - Operational update
22Apr22 07:00 RNS
Advanced Oncotherapy - Update re admission of Subscription Shares
19Apr22 16:05 RNS
Advanced Oncotherapy - Update re admission of Subscription Shares
12Apr22 07:13 RNS
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
31Mar22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
25Mar22 09:30 RNS
Advanced Oncotherapy - £2m Subscription, Add'l Loan and Issue of Warrants
14Mar22 07:15 DGAP-News
Hardman & Co Research: Advanced Oncotherapy (AVO) - LIGHT: regulatory update
04Mar22 09:00 RNS
Advanced Oncotherapy - Director/PDMR Notification
03Mar22 17:05 RNS
Advanced Oncotherapy - Director/PDMR Notification
02Mar22 16:10 RNS
Advanced Oncotherapy - Director/PDMR Notification
01Mar22 07:00 RNS
Advanced Oncotherapy - Operational update
28Feb22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
17Feb22 16:25 RNS
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
31Jan22 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
13Jan22 15:17 RNS
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
31Dec21 13:00 RNS
Advanced Oncotherapy - Total Voting Rights
13Dec21 07:00 RNS
Advanced Oncotherapy - Technical update on delivery of first LIGHT system
02Dec21 13:29 RNS
Advanced Oncotherapy - Issue of warrants and equity and Loan Extension
30Nov21 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
15Nov21 08:30 DGAP-News
Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
08Nov21 14:28 RNS
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
27Oct21 07:00 RNS
Advanced Oncotherapy - Presentation highlights LIGHT system superiority
30Sep21 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
30Sep21 07:00 RNS
Advanced Oncotherapy - Interim Results
23Sep21 11:27 RNS
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
20Sep21 07:00 RNS
Advanced Oncotherapy - Update re admission of Subscription Shares
03Sep21 07:00 RNS
Advanced Oncotherapy - Update on admission of Subscription Shares
31Aug21 18:14 RNS
Advanced Oncotherapy - Result of GM, TVR and clarification re warrants
16Aug21 16:48 RNS
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
12Aug21 13:50 DGAP-News
Hardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion
11Aug21 07:00 RNS
Advanced Oncotherapy - Proposed subscription and issuance of shares
02Aug21 15:37 RNS
Advanced Oncotherapy - Result of AGM
30Jul21 16:58 RNS
Advanced Oncotherapy - Result of AGM
13Jul21 14:19 RNS
Advanced Oncotherapy - Holdings in company
30Jun21 07:00 RNS
Advanced Oncotherapy - Final Results for the year ended 31 December 2020
03Jun21 07:00 RNS
Advanced Oncotherapy - Saba Partners sign LOI for LIGHT system
28May21 17:00 RNS
Advanced Oncotherapy - Total Voting Rights
26May21 10:37 RNS
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
28Apr21 17:38 RNS
Exercise of Warrants and Issue of Equity
31Mar21 17:00 RNS
Total Voting Rights
12Mar21 07:00 RNS
Study shows the potential superiority of LIGHT
11Mar21 07:00 RNS
Exercise of Warrants and Issue of Equity
26Feb21 17:00 RNS
Total Voting Rights
17Feb21 10:39 RNS
Exercise of Warrants and Issue of Equity
22Jan21 07:00 RNS
Equity fundraise of c.£5.9m
13Jan21 07:00 RNS
Exercise of Warrants and Issue of Equity
Date / Time Company % Chg
09May24 07:00
AIM - Cancellation - Advanced Oncotherapy Plc
03May24 08:54
Advanced Oncotherapy - Further update on financing discussions
02Apr24 15:50
Advanced Oncotherapy - Further update on financing discussions
29Feb24 17:19
Advanced Oncotherapy - Further update on financing discussions
01Feb24 07:00
Advanced Oncotherapy - Further update on financing discussions
09Jan24 09:00
Advanced Oncotherapy - Update on Financing Discussions
23Oct23 07:00
Advanced Oncotherapy - Update on Financing and Current Financial Position
29Sep23 16:04
Advanced Oncotherapy - Update on Financial Results
17Jul23 07:00
Advanced Oncotherapy - Recapitalisation and funding plan, update on FSP
30Jun23 17:00
Advanced Oncotherapy - Total Voting Rights
30Jun23 07:30
AIM - Suspension - Advanced Oncotherapy PLC
30Jun23 07:15
Advanced Oncotherapy - Update on financing, suspension of trading on AIM
26Jun23 10:57
Advanced Oncotherapy - Partial conversion of Convertible Notes
19Jun23 17:56
Advanced Oncotherapy - Partial conversion of Convertible Notes
16Jun23 18:23
Advanced Oncotherapy - Issue of warrants
31May23 17:57
Advanced Oncotherapy - Update on financing and convertible notes
15May23 11:36
Advanced Oncotherapy - Update on Convertible Note & Loan Extension
05May23 07:00
Advanced Oncotherapy - Additional funding from Secured Convertible Note
03May23 18:19
Advanced Oncotherapy - Rule 2.9 Announcement
18Apr23 07:00
Advanced Oncotherapy - Strategic review and formal sale process
20Mar23 12:36
Advanced Oncotherapy - Update on Secured Convertible Note Facility
01Mar23 14:54
Advanced Oncotherapy - Secured Convertible Note Facility & other matters
27Jan23 16:53
Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date
18Jan23 14:00
Advanced Oncotherapy - Operational update
17Jan23 15:10
Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV
30Dec22 13:00
Advanced Oncotherapy - Total Voting Rights
30Dec22 09:24
Advanced Oncotherapy - Director/PDMR Shareholding
29Dec22 15:12
Advanced Oncotherapy - Director/PDMR Shareholding
28Dec22 07:00
Advanced Oncotherapy - Director/PDMR Shareholding
12Dec22 07:00
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
01Dec22 07:00
Advanced Oncotherapy - Issue of Equity
28Nov22 07:00
Advanced Oncotherapy - Study showcases the potential superiority of LIGHT
03Nov22 15:20
Advanced Oncotherapy - Investor / Analyst Event Update
31Oct22 17:00
Advanced Oncotherapy - Total Voting Rights
27Oct22 07:31
Advanced Oncotherapy - Presentation highlights superiority of LIGHT
21Oct22 07:00
Advanced Oncotherapy - Notice of Investor / Analyst Event
18Oct22 07:00
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
30Sep22 17:00
Advanced Oncotherapy - Total Voting Rights
30Sep22 07:00
Advanced Oncotherapy - Interim Results
29Sep22 07:15
Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
27Sep22 10:30
Advanced Oncotherapy - LIGHT accelerator fully operational
31Aug22 17:00
Advanced Oncotherapy - Total Voting Rights
23Aug22 15:09
Advanced Oncotherapy - Update re admission of Subscription Shares
19Aug22 07:00
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
03Aug22 07:00
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
29Jul22 16:30
Advanced Oncotherapy - Result of AGM
30Jun22 17:00
Advanced Oncotherapy - Total Voting Rights
30Jun22 09:00
Advanced Oncotherapy - Final results for the year ended 31 December 2021
28Jun22 07:00
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
13Jun22 07:00
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
31May22 17:00
Advanced Oncotherapy - Total Voting Rights
11May22 07:00
Advanced Oncotherapy - LIGHT system potential in delivering FLASH
29Apr22 17:00
Advanced Oncotherapy - Total Voting Rights
27Apr22 07:00
Advanced Oncotherapy - Video showcases progress on LIGHT system process
26Apr22 07:00
Advanced Oncotherapy - Operational update
22Apr22 07:00
Advanced Oncotherapy - Update re admission of Subscription Shares
19Apr22 16:05
Advanced Oncotherapy - Update re admission of Subscription Shares
12Apr22 07:13
Advanced Oncotherapy - Equity Subscription and Issue of Warrants
31Mar22 17:00
Advanced Oncotherapy - Total Voting Rights
25Mar22 09:30
Advanced Oncotherapy - £2m Subscription, Add'l Loan and Issue of Warrants
14Mar22 07:15
Hardman & Co Research: Advanced Oncotherapy (AVO) - LIGHT: regulatory update
04Mar22 09:00
Advanced Oncotherapy - Director/PDMR Notification
03Mar22 17:05
Advanced Oncotherapy - Director/PDMR Notification
02Mar22 16:10
Advanced Oncotherapy - Director/PDMR Notification
01Mar22 07:00
Advanced Oncotherapy - Operational update
28Feb22 17:00
Advanced Oncotherapy - Total Voting Rights
17Feb22 16:25
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
31Jan22 17:00
Advanced Oncotherapy - Total Voting Rights
13Jan22 15:17
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
31Dec21 13:00
Advanced Oncotherapy - Total Voting Rights
13Dec21 07:00
Advanced Oncotherapy - Technical update on delivery of first LIGHT system
02Dec21 13:29
Advanced Oncotherapy - Issue of warrants and equity and Loan Extension
30Nov21 17:00
Advanced Oncotherapy - Total Voting Rights
15Nov21 08:30
Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
08Nov21 14:28
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
27Oct21 07:00
Advanced Oncotherapy - Presentation highlights LIGHT system superiority
30Sep21 17:00
Advanced Oncotherapy - Total Voting Rights
30Sep21 07:00
Advanced Oncotherapy - Interim Results
23Sep21 11:27
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
20Sep21 07:00
Advanced Oncotherapy - Update re admission of Subscription Shares
03Sep21 07:00
Advanced Oncotherapy - Update on admission of Subscription Shares
31Aug21 18:14
Advanced Oncotherapy - Result of GM, TVR and clarification re warrants
16Aug21 16:48
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
12Aug21 13:50
Hardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion
11Aug21 07:00
Advanced Oncotherapy - Proposed subscription and issuance of shares
02Aug21 15:37
Advanced Oncotherapy - Result of AGM
30Jul21 16:58
Advanced Oncotherapy - Result of AGM
13Jul21 14:19
Advanced Oncotherapy - Holdings in company
30Jun21 07:00
Advanced Oncotherapy - Final Results for the year ended 31 December 2020
03Jun21 07:00
Advanced Oncotherapy - Saba Partners sign LOI for LIGHT system
28May21 17:00
Advanced Oncotherapy - Total Voting Rights
26May21 10:37
Advanced Oncotherapy - Exercise of Warrants and Issue of Equity
28Apr21 17:38
Exercise of Warrants and Issue of Equity
31Mar21 17:00
Total Voting Rights
12Mar21 07:00
Study shows the potential superiority of LIGHT
11Mar21 07:00
Exercise of Warrants and Issue of Equity
26Feb21 17:00
Total Voting Rights
17Feb21 10:39
Exercise of Warrants and Issue of Equity
22Jan21 07:00
Equity fundraise of c.£5.9m
13Jan21 07:00
Exercise of Warrants and Issue of Equity